Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Theisen, Benjamin [VerfasserIn]   i
 Lichtenstern, Christoph [VerfasserIn]   i
 Nußhag, Christian [VerfasserIn]   i
 Tan, Benjamin [VerfasserIn]   i
 Hölle, Tobias [VerfasserIn]   i
 Weigand, Markus A. [VerfasserIn]   i
 Kalenka, Armin [VerfasserIn]   i
 Fiedler-Kalenka, Mascha [VerfasserIn]   i
Titel:Simultaneous removal of endotoxins, inflammatory mediators and uremic toxins in ICU patients with septic shock
Titelzusatz:a retrospective cohort study
Verf.angabe:Benjamin E. Theisen, Christoph Lichtenstern, Christian Nusshag, Benjamin Tan, Tobias Hölle, Markus A. Weigand, Armin Kalenka & Mascha O. Fiedler-Kalenka
E-Jahr:2024
Jahr:23 August 2024
Umfang:15 S.
Illustrationen:Illustrationen
Fussnoten:Gesehen am 19.09.2024
Titel Quelle:Enthalten in: Scientific reports
Ort Quelle:[London] : Springer Nature, 2011
Jahr Quelle:2024
Band/Heft Quelle:14(2024), Artikel-ID 19645, Seite 1-15
ISSN Quelle:2045-2322
Abstract:Sepsis, one of the leading causes of death, is still lacking specific treatment. OXIRIS (BAXTER, Deerfield, IL, USA) is the first device allowing combined removal of endotoxins, inflammatory mediators and uremic toxins, alongside fluid balance control. Available data is very limited. This retrospective propensity score-matched cohort study of adult patients with septic shock aimed to evaluate septic shock duration and mortality in patients treated with either standard of care renal replacement therapy (RRT) or RRT with combined hemoadsorption, who were admitted to the interdisciplinary surgical intensive care unit at Heidelberg University Hospital during the years 2018 through 2021. Main outcomes were duration of shock, thirty-day mortality and plasma interleukin-6 levels before and after initiation of hemoadsorption. Included were 117 patients (female, 33%; male 67%); median age: 67 (16) years. After matching: 42 patients (female, 33%; male, 67%); mean age: 59.1 ± 13.8 years. There was no statistically significant difference in septic shock duration (p = 0.94; hazard ratio (HR) 0.97 (95% CI, 0.48-1.97)). Thirty-day survival analysis showed a non-statistically significant survival difference. (p = 0.063; HR 0.43 (95% CI, 0.17-1.09)). A post-hoc 90-day survival analysis revealed statistically significant longer survival and lower death hazard ratio in patients treated with RRT + HA (p = 0.037; HR = 0.42 (95% CI, 0.18-0.99). In conclusion, RRT with combined hemoadsorption of endotoxins, inflammatory mediators and uremic toxins is a modality worth further investigation.
DOI:doi:10.1038/s41598-024-70522-3
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

kostenfrei: Volltext: https://doi.org/10.1038/s41598-024-70522-3
 kostenfrei: Volltext: https://www.nature.com/articles/s41598-024-70522-3
 DOI: https://doi.org/10.1038/s41598-024-70522-3
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Bacterial infection
 Cardiovascular diseases
 Health care
 Immunological disorders
 Infectious diseases
 Kidney diseases
 Renal replacement therapy
K10plus-PPN:1903000351
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69254719   QR-Code
zum Seitenanfang